Reichindia Bio - Applications Profile
Key Indicators
- Authorised Capital ₹ 1.30 Cr
as on 13-12-2024
- Paid Up Capital ₹ 3.00 M
as on 13-12-2024
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.45 Cr
as on 13-12-2024
- Satisfied Charges ₹ 6.80 M
as on 13-12-2024
- Revenue 10.90%
(FY 2020)
- Profit -90.91%
(FY 2020)
- Ebitda -74.38%
(FY 2020)
- Net Worth 0.26%
(FY 2020)
- Total Assets -35.62%
(FY 2020)
About Reichindia Bio - Applications
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.30 Cr and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹3.45 Cr. The company has closed loans amounting to ₹6.80 M, as per Ministry of Corporate Affairs (MCA) records.
Syam Chidara, Chidara Neelima, and Gandavarapu Sharma serve as directors at the Company.
- CIN/LLPIN
U24233TG2011PLC075232
- Company No.
075232
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
28 Jun 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Reichindia Bio - Applications?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Syam Chidara  | Director | 28-Jun-2011 | Current |
| Chidara Neelima | Director | 28-Jun-2011 | Current |
| Gandavarapu Sharma | Director | 27-Dec-2017 | Current |
Financial Performance of Reichindia Bio - Applications.
Reichindia Bio - Applications Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 10.9% increase. The company also saw a substantial fall in profitability, with a 90.91% decrease in profit. The company's net worth moved up by a moderate rise of 0.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reichindia Bio - Applications?
In 2020, Reichindia Bio - Applications had a promoter holding of 90.67% and a public holding of 9.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 02 Jun 2023 | ₹3.40 Cr | Open |
Others Creation Date: 15 Apr 2023 | ₹0.54 M | Open |
State Bank Of India Creation Date: 17 Jun 2014 | ₹0.80 M | Satisfied |
How Many Employees Work at Reichindia Bio - Applications?
Unlock and access historical data on people associated with Reichindia Bio - Applications, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reichindia Bio - Applications, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reichindia Bio - Applications's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
